440.1 Longitudinal assessment of health-related quality of life in patients with chronic kidney disease
Owen Ng, Australia
440.2 Clinical study of the importance of IgG level in kidney transplant recipient
Dr. Yasushi Mochizuki, Japan
440.3 Reported cancer screening practices by healthcare professionals for kidney transplant candidates and recipients
Dr. Nida Saleem, Australia
440.4 Does de novo malignancy increase the risk of rejection in kidney transplant recipients?
Aydın Turkmen, Turkey
440.5 Immunosuppressive drug combinations after kidney transplantation and post-transplant diabetes: a systematic review and meta-analysis
Dr. Nuria Montero Perez, Spain
440.6 Efficacy and safety of 6-month sacubitril/valsartan administration in post-renal transplant patients; possibly contribution to long-term graft survival?
Michiko Shimada, Japan
440.7 Pre-emptive first deceased donor renal transplant: A matched cohort study
Dr. Antonio Franco Esteve, Spain
440.8 Delayed initiation or reduced initial dose of calcineurin-inhibitors for kidney transplant recipients: A systematic review and meta-analysis